Showing results (2061-2070 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|December 1, 1995
Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide KE Yefenof, I Gafanovitch, E Oron, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1996
Protective effect of an acidic glycoprotein obtained from culture of Chlorella vulgaris against myelosuppression by 5-fluorouracilF Konishi, M Mitsuyama, M Okuda, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1996
Suppressive effects of Lactobacillus casei cells, a bacterial immunostimulant, on the incidence of spontaneous thymic lymphoma in AKR miceT Watanabe
Cancer Immunology, Immunotherapy : CII|June 1, 1996
99mTc-CD19 monoclonal antibody is not useful for imaging of B cell non-Hodgkin's lymphomaS F Vervoordeldonk, J Heikens, W T Goedemans, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1997
Human ex vivo carcinoma cells produce transforming growth factor beta and thereby can inhibit lymphocyte functions in vitroF Vánky, N Nagy, C Hising, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1997
A survivor of breast cancer with immunity to MUC-1 mucin, and lactational mastitisK R Jerome, A D Kirk, G Pecher, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 1996
Combination immunotherapy with OK-432, recombinant granulocyte-colony-stimulating factor and recombinant interleukin-2 for human hepatocellular carcinomaT Himoto, S Watanabe, M Nishioka, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 1996
Eradication of established hepatic human neuroblastoma metastases in mice with severe combined immunodeficiency by antibody-targeted interleukin-2J D Pancook, J C Becker, S D Gillies, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1996
Phenotypic, functional and molecular analysis of lymphocytes associated with bladder cancerS Bruno, A M Machí, C Semino, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1993
Tumoricidal effect of human macrophage-colony-stimulating factor against human-ovarian-carcinoma-bearing athymic mice and its therapeutic effect when combined with cisplatinT Adachi, H Mano, Y Shinohara, et al.
Pageof 652